trimethoprim has been researched along with Hypopigmentation in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among the different modalities for treatment of cutaneous leishmaniasis, liquid nitrogen is considered an effective therapy with very mild side-effects." | 2.68 | A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. ( Abuloham, O; al-Majali, O; Bhowmik, KR; Hebeheba, H; Muhsen, M; Routh, HB, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Majali, O | 1 |
| Routh, HB | 1 |
| Abuloham, O | 1 |
| Bhowmik, KR | 1 |
| Muhsen, M | 1 |
| Hebeheba, H | 1 |
1 trial available for trimethoprim and Hypopigmentation
| Article | Year |
|---|---|
A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents; Antimony; Cicatrix; Cryosurgery | 1997 |